Healthcare digital transformation cases sit at the intersection of two consulting megatrends: the $200+ billion healthtech market and the ongoing shift from fee-for-service to value-based care. Based on our analysis of 800+ consulting case interviews, digital health scenarios now appear in roughly 12–15% of healthcare cases at MBB firms — up from near zero five years ago.
Why Digital Health Cases Are Appearing More Often
Three market forces are driving the rise of digital health cases in consulting interviews:
| Driver | Market Signal | Case Implication |
|---|---|---|
| Post-pandemic telehealth adoption | Virtual visits grew from 1% to 17% of outpatient encounters | Revenue model redesign, capacity planning |
| AI/ML regulatory maturation | FDA has cleared 800+ AI medical devices since 2018 | Build vs. buy decisions, clinical validation frameworks |
| Payer-mandated digitization | CMS interoperability rules requiring open APIs by 2026 | Compliance investment, data monetization strategy |
| Venture capital influx | $30B+ invested in digital health in peak years | Partnership vs. acquisition, competitive positioning |
In our experience working with candidates at McKinsey, BCG, and Bain, digital health cases test whether you can combine traditional healthcare industry knowledge with technology strategy thinking.
The Five Sub-Sectors You Must Know
Healthcare digital transformation is not one topic. Each sub-sector has distinct economics, regulatory constraints, and go-to-market dynamics.
mindmap
root((Healthcare Digital Transformation))
Telehealth
Synchronous video visits
Asynchronous messaging
Remote patient monitoring
AI & Clinical Decision Support
Diagnostic imaging AI
Predictive analytics
Clinical NLP
EHR & Data Infrastructure
Interoperability
Cloud migration
Data lakes
Digital Therapeutics
Prescription digital apps
Behavioral health platforms
Chronic disease management
Connected Devices & IoT
Wearables
Remote monitors
Smart implants
Structuring a Digital Health Case
The core challenge in digital health cases is balancing clinical value with commercial viability while navigating regulatory constraints. A three-lens framework handles most scenarios:
flowchart TD
A[Digital Health Case Prompt] --> B{Identify Sub-Sector}
B --> C[Clinical Value Lens]
B --> D[Commercial Viability Lens]
B --> E[Regulatory & Integration Lens]
C --> C1[Clinical evidence tier?]
C --> C2[Patient outcome improvement?]
C --> C3[Physician workflow impact?]
D --> D1[Revenue model?]
D --> D2[Payer willingness to reimburse?]
D --> D3[Patient acquisition cost?]
E --> E1[FDA classification needed?]
E --> E2[EHR integration complexity?]
E --> E3[Data privacy requirements?]
C1 --> F[Recommendation]
D3 --> F
E3 --> F
Lens 1: Clinical Value
Digital health solutions only scale if they demonstrably improve outcomes. Interviewers expect you to assess:
- Evidence tier: Is there randomized controlled trial (RCT) data, or only pilot results?
- Clinical endpoint: Does the solution reduce hospitalizations, improve adherence, or shorten time-to-diagnosis?
- Physician adoption barrier: Does it add to workflow or replace existing steps?
Lens 2: Commercial Viability
Healthcare reimbursement determines whether a digital solution generates revenue. Key questions:
- Reimbursement pathway: Is there a CPT code for the service? Does the payer cover it?
- Revenue model: Per-member-per-month (PMPM), fee-per-encounter, or SaaS license?
- Unit economics: What is the patient acquisition cost relative to lifetime value?
Lens 3: Regulatory and Integration
Technology alone does not create value in healthcare — integration into existing clinical workflows does.
- FDA pathway: Is the solution a Class I, II, or III device? Does it need 510(k) or De Novo classification?
- Interoperability: Can it exchange data via HL7 FHIR with existing EHR systems?
- HIPAA/data governance: How is protected health information (PHI) stored and transmitted?
Common Case Archetypes
Based on our review of consulting interview patterns, healthcare digital transformation cases typically fall into four archetypes:
| Archetype | Sample Prompt | Key Analysis |
|---|---|---|
| Telehealth expansion | “A health system wants to launch a virtual care platform. Should they build or buy?” | Build vs. buy cost analysis, patient volume forecasting, reimbursement parity |
| AI diagnostic tool adoption | “A radiology group is evaluating an AI tool for breast cancer screening. Should they adopt it?” | Clinical accuracy metrics, liability allocation, workflow integration, ROI |
| EHR modernization | “A 200-physician practice is considering migrating from a legacy EHR. Evaluate the business case.” | Migration cost, productivity loss during transition, long-term savings |
| Digital therapeutics launch | “A pharma company wants to launch a prescription digital app for diabetes management.” | FDA regulatory pathway, payer reimbursement strategy, patient engagement model |
Telehealth Case Deep Dive
Telehealth cases are the most common digital health scenario. The economics hinge on a simple equation:
Telehealth Margin = (Reimbursement Rate × Visit Volume) − (Platform Cost + Provider Time + Patient Acquisition)
Key data points interviewers expect you to know:
- Average telehealth reimbursement: 85–100% of in-person rates for many specialties (post-pandemic policy changes)
- No-show rates: typically 5–8% for telehealth vs. 15–20% for in-person
- Provider throughput: 15–20% more patients per hour in virtual settings for follow-up visits
- Patient satisfaction: 85–90% satisfaction scores in primary care, lower for complex specialty visits
When structuring a telehealth case, segment by visit type — new patient vs. follow-up, primary care vs. specialty — because economics differ dramatically across segments.
AI Diagnostics Case Deep Dive
AI diagnostic cases test your ability to evaluate technology through a clinical and commercial lens simultaneously. The critical distinction is between AI-assisted (physician reviews AI output) and AI-autonomous (AI makes independent decisions), as regulatory requirements diverge sharply.
| Dimension | AI-Assisted | AI-Autonomous |
|---|---|---|
| FDA pathway | 510(k) typically sufficient | De Novo or PMA required |
| Liability | Physician retains liability | Manufacturer and institution share liability |
| Reimbursement | Bundled into existing procedure codes | May require new CPT code |
| Adoption speed | Faster (physician in loop) | Slower (institution risk aversion) |
| Accuracy threshold | Must match physician baseline | Must exceed physician performance |
Practice Prompt: Virtual Care Expansion
Your client is a regional health system with 12 hospitals and 400 outpatient clinics. They launched telehealth during the pandemic and now conduct 25% of outpatient visits virtually. The CEO wants to evaluate whether to expand to 50% virtual visits within two years. What factors would you analyze?
Suggested structure:
- Demand segmentation: Which specialties and visit types are suitable for virtual delivery? (Follow-ups, behavioral health, dermatology: high suitability. Surgery consults, physical exams: low suitability)
- Capacity impact: Will reducing in-person visits free physical space, or will demand simply shift to more complex cases?
- Financial model: Compare per-visit margin across channels, accounting for reduced no-shows but potential revenue loss from ancillary services
- Physician and patient experience: Provider burnout risk from screen fatigue; patient population digital literacy
- Technology infrastructure: Can the existing platform handle 2× volume? What about EHR integration depth?
Key Takeaways
- Healthcare digital transformation cases combine traditional healthcare knowledge (regulation, reimbursement, stakeholders) with technology strategy (build vs. buy, platform economics, data governance)
- Use the three-lens framework — clinical value, commercial viability, regulatory/integration — to structure any digital health case
- Telehealth economics depend heavily on visit-type segmentation and reimbursement parity policies
- AI diagnostic cases require distinguishing between assisted and autonomous pathways, as regulatory and liability implications differ dramatically
- Always quantify the clinical evidence tier before assessing commercial potential — solutions without RCT-level data face steep adoption barriers
- EHR integration complexity is often the hidden cost that breaks digital health business cases
Ready to practice healthcare cases with industry-specific scenarios? Start with our Healthcare Industry Deep Dive for foundational knowledge, explore healthcare industry cases in our case library, or sharpen your skills with an AI Mock Interview focused on healthcare digital transformation prompts.